Experts outline parameters for myopia control trials

SILVER SPRING, Md. – Patient selection, efficacy endpoints, acceptable rate of microbial keratitis and patient-reported outcomes are all crucial factors in a randomized controlled clinical trial designed to evaluate the effectiveness of a device to control myopia progression, according to expert panelists.Representatives from the major optometry and ophthalmology organizations co-sponsored a workshop held last week at the FDA to suggest guidelines for future clinical trials involving contact lenses with this indication in children.